CanSino Biologics Inc. (SHA:688185)
China · Delayed Price · Currency is CNY 88.05
+0.50 (0.57%)
Aug 25, 2025, 2:45 PM CST
CanSino Biologics Market Cap
CanSino Biologics has a market cap or net worth of 16.41 billion as of August 25, 2025. Its market cap has increased by 134.91% in one year.
Market Cap
16.41B
Enterprise Value
15.02B
Revenue
925.24M
Ranking
n/a
PE Ratio
n/a
Stock Price
88.05
Market Cap Chart
Since March 28, 2019, CanSino Biologics's market cap has increased from 6.50B to 16.41B, an increase of 152.52%. That is a compound annual growth rate of 15.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 25, 2025 | 16.41B | 50.44% |
| Dec 31, 2024 | 10.91B | -3.78% |
| Dec 29, 2023 | 11.34B | -53.71% |
| Dec 30, 2022 | 24.49B | -54.52% |
| Dec 31, 2021 | 53.86B | -14.04% |
| Dec 31, 2020 | 62.66B | 434.03% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 28, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 432.34B |
| Shenzhen Mindray Bio-Medical Electronics | 295.39B |
| WuXi AppTec | 275.20B |
| Sichuan Biokin Pharmaceutical | 133.02B |
| Zhangzhou Pientzehuang Pharmaceutical., | 129.26B |
| Aier Eye Hospital Group | 124.56B |
| Shanghai United Imaging Healthcare | 111.01B |
| Yunnan Baiyao Group Co.,Ltd | 102.84B |